ABEONA THERAPEUTICS INC. (ABEO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, ABEONA THERAPEUTICS INC. reported revenue of $5.82M. The company was profitable, with a net margin of 1223.1%. It held $219.57M in total assets against $60.35M in total liabilities.
Key ratios (FY2025)
-1536.9%
Operating margin
1223.1%
Net margin
44.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.82M | — | $3.50M | $1.41M | $3.00M | $10.00M | — | $3.00M | $837.0K | — |
| Cost of Revenue | $1.53M | — | — | — | — | — | — | — | — | — |
| Operating Income | -$89.45M | -$64.21M | -$47.13M | -$50.91M | -$89.84M | -$81.42M | -$77.09M | -$58.17M | -$27.84M | -$23.88M |
| Net Income | $71.18M | -$63.73M | -$54.19M | -$39.70M | -$84.94M | -$84.23M | -$76.28M | -$56.67M | -$27.32M | -$21.87M |
| EPS (Diluted) | $1.34 | $-1.55 | $-2.53 | $-5.53 | $-21.57 | — | — | — | — | — |
| Total Assets | $219.57M | $108.93M | $64.00M | $64.21M | $79.59M | $151.20M | $223.38M | $174.40M | $178.77M | $111.06M |
| Total Liabilities | $60.35M | $64.90M | $49.18M | $37.45M | $37.22M | $48.65M | $44.95M | $40.35M | $8.67M | $11.96M |
| Shareholders' Equity | $159.22M | $44.03M | $14.83M | $26.76M | $42.37M | $102.55M | $178.43M | $134.04M | $170.10M | $99.10M |
| Cash & Equivalents | $78.44M | $23.36M | $14.47M | $14.22M | $32.94M | $12.60M | $129.26M | $18.75M | $137.75M | $69.14M |
| Operating Cash Flow | -$76.33M | -$56.02M | -$37.01M | -$43.48M | -$65.67M | -$35.02M | -$62.82M | -$39.11M | -$22.66M | -$13.01M |
| Capital Expenditures | $7.97M | $2.45M | $331.0K | $130.0K | $4.15M | $1.34M | $6.31M | $9.24M | $860.0K | $519.0K |
| Shares Outstanding | 55.04M | 45.64M | 26.52M | 17.72M | 5.89M | 96.13M | 83.62M | 47.94M | 46.89M | 40.25M |